Bairlein, M. (2010). Characterization of the small molecule kinase inhibitor SU11248 (Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer therapy with kinase inhibitors. PhD Thesis, Technische Universität, München.